129 related articles for article (PubMed ID: 29257751)
1. Measuring procalcitonin to overcome heterophilic-antibody-induced spurious hypercalcitoninemia.
Giovanella L; Giordani I; Imperiali M; Orlandi F; Trimboli P
Clin Chem Lab Med; 2018 Jul; 56(8):e191-e193. PubMed ID: 29257751
[No Abstract] [Full Text] [Related]
2. Comparison of the Elecsys calcitonin assay with the Immulite 1000 assay. Describing one case with heterophilic antibody interference.
Bories PN; Broutin A; Delette A; Labelle G; Popovici T
Clin Chem Lab Med; 2016 Feb; 54(2):e45-7. PubMed ID: 26351952
[No Abstract] [Full Text] [Related]
3. Spurious hypercalcitoninemia in patients with nodular thyroid disease induced by heterophilic antibodies.
Kim JM; Chung KW; Kim SW; Choi SH; Min HS; Kim JN; Won WJ; Kim SK; Lee JI; Chung JH; Kim SW
Head Neck; 2010 Jan; 32(1):68-75. PubMed ID: 19536770
[TBL] [Abstract][Full Text] [Related]
4. Spurious hypercalcitoninemia and heterophilic antibodies in patients with thyroid nodules.
Giovanella L; Suriano S
Head Neck; 2011 Jan; 33(1):95-7. PubMed ID: 20848426
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin Screening - Consideration of Heterophilic Antibody Interference in a Case of Obscure Hypercalcitoninemia.
Seifert P; Kloos E; Ritter K; Freesmeyer M
Nuklearmedizin; 2020 Feb; 59(1):35-37. PubMed ID: 31958863
[No Abstract] [Full Text] [Related]
6. Heterophilic antibodies causing falsely high serum calcitonin values.
Papapetrou PD; Polymeris A; Karga H; Vaiopoulos G
J Endocrinol Invest; 2006 Nov; 29(10):919-23. PubMed ID: 17185902
[TBL] [Abstract][Full Text] [Related]
7. False serum calcitonin high levels using a non-competitive two-site IRMA.
Tommasi M; Brocchi A; Cappellini A; Raspanti S; Mannelli M
J Endocrinol Invest; 2001 May; 24(5):356-60. PubMed ID: 11407656
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of patients with hypercalcitoninemia after initial treatment for medullary thyroid cancer and postoperative serum calcitonin cutoffs for predicting structural recurrence.
Cho YY; Jang HW; Jang JY; Kim TH; Choe JH; Kim JH; Kim JS; Kim SW; Chung JH
Head Neck; 2016 Oct; 38(10):1501-8. PubMed ID: 27062421
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.
Woliński K; Kaznowski J; Klimowicz A; Maciejewski A; Łapińska-Cwojdzińska D; Gurgul E; Car AD; Fichna M; Gut P; Gryczyńska M; Ruchała M
Endokrynol Pol; 2017; 68(4):434-437. PubMed ID: 28585679
[TBL] [Abstract][Full Text] [Related]
10. A case of spurious hypercalcitoninemia: a cautionary tale on the use of plasma calcitonin assays in the screening of patients with thyroid nodules for neoplasia.
Uwaifo GI; Remaley AT; Stene M; Reynolds JC; Yen PM; Snider RH; Becker KL; Sarlis NJ
J Endocrinol Invest; 2001 May; 24(5):361-9. PubMed ID: 11407657
[TBL] [Abstract][Full Text] [Related]
11. Negative predictive value of procalcitonin in medullary thyroid carcinoma.
Lim SK; Guéchot J; Vaubourdolle M
Ann Biol Clin (Paris); 2016; 74(2):213-8. PubMed ID: 26806393
[TBL] [Abstract][Full Text] [Related]
12. Case Report: Medullary Thyroid Cancer Workup Initiated by Unexpectedly High Procalcitonin Level-Endocrine Training Saves Life in the COVID-19 Unit.
Sira L; Balogh Z; Vitális E; Kovács D; Győry F; Molnár C; Bodor M; Nagy EV
Front Endocrinol (Lausanne); 2021; 12():727320. PubMed ID: 34707568
[TBL] [Abstract][Full Text] [Related]
13. [Semi quantitative determination of blood procalcitonin by the immunochromatographic BRAHMS PCT-Q test: false positive result].
Desvignes P; Boutib A
Ann Biol Clin (Paris); 2005; 63(3):358-9. PubMed ID: 15981317
[No Abstract] [Full Text] [Related]
14. Eliminating heterophilic antibody interference for ferritin detection using Olympus F(ab')2 based reagent.
Grouzmann E; Dayer N; Bain C; Neville CM; McCusker MD; Wang RY
Clin Lab; 2008; 54(9-10):355-7. PubMed ID: 19097493
[TBL] [Abstract][Full Text] [Related]
15. Insulinoma with Hyperprocalcitoninemia and Hypercalcitoninemia Showing Coexpression of Insulin and Calcitonin in Its Tumor Cells.
Kaketaka T; Mineo I; Kimura Y; Ito N; Okauchi Y; Tamura H; Adachi S; Iwahashi H
Intern Med; 2024 May; 63(10):1415-1420. PubMed ID: 37839887
[TBL] [Abstract][Full Text] [Related]
16. Utility of serum procalcitonin for screening and risk stratification of medullary thyroid cancer.
Machens A; Lorenz K; Dralle H
J Clin Endocrinol Metab; 2014 Aug; 99(8):2986-94. PubMed ID: 24840813
[TBL] [Abstract][Full Text] [Related]
17. Repeated spurious elevation of serum prostate-specific antigen values solved by chemiluminescence analysis: A possible interference by heterophilic antibodies.
Domínguez A; Bayó M; Muñoz-Rodríguez J; Bellido JA; Abascal-Junquera JM; Hannaoui N; Banús JM
Korean J Urol; 2015 Nov; 56(11):785-7. PubMed ID: 26568798
[TBL] [Abstract][Full Text] [Related]
18. Procalcitonin for detecting medullary thyroid carcinoma: a systematic review.
Trimboli P; Seregni E; Treglia G; Alevizaki M; Giovanella L
Endocr Relat Cancer; 2015 Jun; 22(3):R157-64. PubMed ID: 25934688
[TBL] [Abstract][Full Text] [Related]
19. False-positive serum chromogranin A assay due to heterophile antibody interference.
Giovanella L; Ceriani L; Lumastro C; Ghelfo A
Clin Chim Acta; 2007 Apr; 379(1-2):171-2. PubMed ID: 17240364
[No Abstract] [Full Text] [Related]
20. [Calcitonin-producing neuroendocrine carcinoma of the larynx: atypical carcinoid tumor].
Morales C; Tomás Bezos J; Alvarez-Quiñones Sanz M; García Mantilla J; Carrera F
Acta Otorrinolaringol Esp; 1996; 47(4):333-5. PubMed ID: 8962741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
